☰

Thomas W. Chalberg, Ph.D. - Publications

Affiliations: 
2006 Stanford University, Palo Alto, CA 
Area:
Genetics, Ophthalmology, Pathology
Tree Info Grants Similar researchers PubMed Report error

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Kotterman MA, Chalberg TW, Schaffer DV. Viral Vectors for Gene Therapy: Translational and Clinical Outlook. Annual Review of Biomedical Engineering. 17: 63-89. PMID 26643018 DOI: 10.1146/Annurev-Bioeng-071813-104938  0.369
2015 Rakoczy EP, Lai CM, Magno AL, Wikstrom ME, French MA, Pierce CM, Schwartz SD, Blumenkranz MS, Chalberg TW, Degli-Esposti MA, Constable IJ. Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial. Lancet (London, England). PMID 26431823 DOI: 10.1016/S0140-6736(15)00345-1  0.359
2015 Rakoczy EP, Lai C, Magno AL, French MA, Chalberg TW, Schwartz SD, Blumenkranz MS, Constable IJ. 394. Baseline Data for Patients Participating in the Phase 2a rAAV.sFlt-1 Gene Therapy Trial for Exudative Age-Related Macular Degeneration Molecular Therapy. 23: S156-S157. DOI: 10.1016/S1525-0016(16)34003-5  0.307
2015 Keravala A, Mi M, Todorov G, Vijay S, Gasmi M, Chalberg TW. 316. Evaluating AAV Hybrid Variants for Improved Tropism after Intravitreal Gene Delivery to the Retina Molecular Therapy. 23: S127-S128. DOI: 10.1016/S1525-0016(16)33925-9  0.423
2015 Neitz M, Neitz J, Crain AC, Chavez CL, Alcamo E, Vijay S, Kniffin T, Moradi E, Ni M, Woodburn KW, Chalberg TW. 202. pMNTC Is a Cone-Specific Regulatory Cassette Designed To Treat Cone-Associated Disorders Molecular Therapy. 23: S80. DOI: 10.1016/S1525-0016(16)33807-2  0.753
2013 Lavinsky D, Chalberg TW, Mandel Y, Huie P, Dalal R, Marmor M, Palanker D. Modulation of transgene expression in retinal gene therapy by selective laser treatment. Investigative Ophthalmology & Visual Science. 54: 1873-80. PMID 23422827 DOI: 10.1167/Iovs.12-10933  0.364
2013 Palanker D, Lavinsky D, Chalberg T, Mandel Y, Huie P, Dalal R, Marmor M. Optical modulation of transgene expression in retinal pigment epithelium Progress in Biomedical Optics and Imaging - Proceedings of Spie. 8567. DOI: 10.1117/12.2001923  0.421
2006 Chalberg TW, Vankov A, Molnar FE, Butterwick AF, Huie P, Calos MP, Palanker DV. Gene transfer to rabbit retina with electron avalanche transfection. Investigative Ophthalmology & Visual Science. 47: 4083-90. PMID 16936128 DOI: 10.1167/Iovs.06-0092  0.649
2006 Chalberg TW, Portlock JL, Olivares EC, Thyagarajan B, Kirby PJ, Hillman RT, Hoelters J, Calos MP. Integration specificity of phage phiC31 integrase in the human genome. Journal of Molecular Biology. 357: 28-48. PMID 16414067 DOI: 10.1016/J.Jmb.2005.11.098  0.728
2006 Palanker D, Chalberg T, Vankov A, Huie P, Molnar FE, Butterwick A, Calos M, Marmor M, Blumenkranz MS. Plasma-mediated transfection of RPE Progress in Biomedical Optics and Imaging - Proceedings of Spie. 6138. DOI: 10.1117/12.649624  0.662
2005 Chalberg TW, Genise HL, Vollrath D, Calos MP. phiC31 integrase confers genomic integration and long-term transgene expression in rat retina. Investigative Ophthalmology & Visual Science. 46: 2140-6. PMID 15914635 DOI: 10.1167/Iovs.04-1252  0.736
2005 Keravala A, Hoelters J, Jarrahian S, Chalberg TW, Ciccarella M, Neth P, Calos MP. 1103. Site-Specific Chromosomal Integration in Human Mesenchymal Stem Cells Mediated by PhiC31 Integrase Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.651  0.824
2005 Chalberg TW, Vankov A, Huie P, Molnar FE, Calos MP, Palanker DV. 770. Novel Physical Methods for Nonviral DNA Transfer to Rabbit Retina Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.311  0.691
2005 Portlock JL, Chalberg TW, Olivares EC, Thyagarajan B, Kirby PJ, Calos MP. 194. Characteristics of Site-Specific Integration as Mediated by PhiC31 Integrase in the Human Genome Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.197  0.733
2004 Chalberg TW, Ginsburg DS, Kirby PJ, Olivares EC, Portlock JL, Thyagarajan B, Calos MP. 814. Integration Sites Used by the PhiC31 Site-Specific Integrase in the Human Genome Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.712  0.66
2004 Chalberg TW, Genise HL, Vollrath D, Calos MP. 1056. PhiC31 Integrase for Long-Term Non-Viral Gene Therapy in Rat Retina Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.1001  0.792
2002 Olivares EC, Hollis RP, Chalberg TW, Meuse L, Kay MA, Calos MP. Site-specific genomic integration produces therapeutic factor IX levels in mice Nature Biotechnology. 20: 1124-1128. PMID 12379870 DOI: 10.1038/Nbt753  0.821
Show low-probability matches.